On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 11/15/22
- Trane commits to low-carbon steel purchases from Nucor, U.S. Steel
- 11/08/22
- U.S. Steel announces tentative agreement with United Steelworkers
- 09/15/22
- U.S. Steel slips after Q3 earnings guidance
- 08/16/22
- U.S. Steel, Equinor and Shell enter a cooperation agreement for clean energy hub
- 12/16/22
- Winnebago CEO says 2023 'critically important' for maintaining momentum
- 11/15/22
- Winnebago presents 2025 targets at investor day
- 11/15/22
- Winnebago to establish dedicated research, development facility
- 10/19/22
- Winnebago falls -10.4%
WBD Warner Bros. Discovery - 12/14/22
- Warner Bros.' game 'Hogwarts Legacy' to launch on Switch July 25, 2023
- 12/06/22
- Warner Bros. Discovery, Amazon.com: HBO Max available on Prime Video in U.S.
- 11/14/22
- U.S. game content spending grew 2% y/y in October, says NPD
- 11/10/22
- Sony says 'Modern Warfare II' tops PS5 digital downloads in October
- 11/25/22
- Travelzoo to sell 3.41M shares to largest shareholder, Azzurro Capital
- 10/26/22
- Travelzoo expects substantially higher revenue and profitability in Q4
- 08/01/22
- Travelzoo trading resumes
- 08/01/22
- Travelzoo trading halted, volatility trading pause
- 12/14/22
- Twitter shutting down newsletter platform Revue
- 12/12/22
- Twitter debuts Blue for Business, gold checkmarks for corporate entities
- 11/30/22
- Musk says Apple CEO never considered removing Twitter from App Store
- 12/16/22
- Trean Insurance to be acquired by Altaris Capital for $6.15 per share in cash
- 07/26/22
- Trean Insurance announces exclusive partnership with Beat Capital
- 11/10/22
- Steel Dynamics announces additional $1.5B share repurchase program
- 11/02/22
- Steel Dynamics selects Columbus, Mississippi, as location for aluminum mill
- 10/19/22
- Steel Dynamics says 'customer order entry activity continues to be healthy'
- 10/04/22
- Steel Dynamics completes acquisition of ROCA ACERO
- 11/28/22
- Sarepta announces FDA grants priority review for SRP-9001 BLA
- 11/14/22
- Soros Fund Management buys Sierra Wireless, exits Kinder Morgan in Q3
- 09/29/22
- Sarepta submits BLA to FDA for accelerated approval of SRP-9001
- 09/14/22
- Sarepta prices $1B of convertible senior notes due 2027
- 12/16/22
- Planet Labs rises 10.2%
- 12/14/22
- Planet Labs makes data available through Amazon Sagemaker
- 12/12/22
- New York Times CFO Roland Caputo to retire
- 11/02/22
- New York Times sees Q4 subscription revenues up 17%-20%
- 08/11/22
- New York Times jumps after ValueAct discloses 6.7% active stake
- 08/03/22
- New York Times sees FY22 CapEx approximately $55M
- 12/16/22
- Here's why Natera is jumping in afternoon trading
- 12/16/22
- ACMG publishes new guideline recommending NIPS for all pregnant individuals
- 12/09/22
- Natera: Published study highlights utility of Signatera test
- 12/06/22
- Natera publishes experience study in twin pregnancies in Prenatal Diagnosis
- 12/16/22
- Meta shutting down Cameo-like app Super
- 12/15/22
- Meta Platforms announces seven new solar projects in Georgia, Tennessee
- 12/13/22
- Rubio, Gallagher introduce bipartisan legislation to ban TikTok
- 12/13/22
- Instagram rolls out Notes for short messaging
- $51.85 /
+28.8 (+124.95%) - 12/16/22
- Maxar Technologies rises 122.5%
- 12/16/22
- Maxar Technologies rises 119.6%
- 12/16/22
- Maxar Technologies rises 120.5%
- 12/16/22
- Satellite stocks take off after Maxar Technologies agrees to go private
- 12/15/22
- IMV Inc. to present initial patient data from VITALIZE trial
- 12/13/22
- IMV begins trading on the TSX and Nasdaq post-reverse stock split
- 12/07/22
- IMV Inc. shareholders approve reverse stock split at 88%
- 09/30/22
- IMV Inc. provides update on VITALIZE study
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 11/29/22
- Stack Capital invests $8M in Locus Robotics
- 11/22/22
- Goldman Sachs Asset Management to pay $4M penalty to settle SEC charges
- 11/16/22
- Goldman Sachs exec sells $3.86M in common stock
- 12/15/22
- Guardant Health reports 'positive' results from ECLIPSE study
- 12/08/22
- Guardant Health announces collaboration with AstraZeneca
- 08/31/22
- Guardant Health expands strategic collaboration with Merck KGaA in oncology
- 08/12/22
- Guardant Health receives FDA approval Guardant360 CDx liquid biopsy test as CDx
- 12/16/22
- Arvinas appoints Everett Cunningham to board of directors
- 12/09/22
- Exact Sciences announces initial clinical validation data for POLAR
- 11/02/22
- Cathie Wood's ARK Investment bought 106.8K shares of Exact Sciences today
- 11/01/22
- Cathie Wood's ARK Investment bought 104K shares of Exact Sciences today
- 12/16/22
- Darden reports Q2 blended same-restaurant sales increase of 7.3%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 09/22/22
- Darden reports Q1 blended same-restaurant sales increase of 4.2%
- 06/23/22
- Darden announces new $1B share repurchase program
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 12/09/22
- Disney+ Basic not currently available on Roku devices
- 12/08/22
- Disney announces ad-supported Disney+ plan available in the U.S.
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 12/16/22
- Centene announces $2B increase to stock repurchase program
- 12/14/22
- Centene announces new leadership appointments
- 12/05/22
- Centene completes divestiture of Magellan Rx to Prime Therapeutics
- 11/17/22
- Centene signs agreement to sell Magellan Specialty Health to Evolent Health
- 12/13/22
- Avaya appoints RingCentral board nominee to board, says committed to partnership
- 11/07/22
- Avaya names Becky Roof named interim CFO amid Kieran McGrath retirement
- 09/06/22
- Avaya sees $23M-$26M in pre-tax charges from workforce reduction
- 08/16/22
- Avaya receives NYSE notice regarding late 10-Q fifling
- 07/17/22
- Fly Intel: Top five weekend stock stories
- 12/15/22
- Agilysys announces agreement with Marriott to deploy PMS software
- 12/15/22
- Adobe says regulatory process for Figma acquisition is proceeding as expected
- 12/06/22
- Adobe Stock to sell AI-generated images
- 11/27/22
- Fly Intel: Top five weekend stock stories
- 10/26/22
- Adobe director sells $5.4M in common stock
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture reports Q1 new bookings $16.22B
- 12/16/22
- Accenture backs FY23 operating cash flow view $8.5B-$9B
- 12/06/22
- Accenture announces sustainability collaboration with Planet Labs
- 12/01/22
- Accenture acquires Fiftyfive5
- 12/13/22
- American Airlines names Devon May Chief Financial Officer
- 12/09/22
- JetBlue, American Airlines add destinations taking off from New York, Boston
- 11/20/22
- Fly Intel: Top five weekend stock stories
- 10/20/22
- American Airlines: Pilot issues to take 2-3 years to work out
- 12/14/22 Argus
- Centene price target raised to $99 from $95 at Argus
- 12/13/22 BofA
- Centene downgraded to Underperform from Neutral at BofA
- 11/23/22 Morgan Stanley
- CVS Health assumed with an Overweight at Morgan Stanley
- 11/18/22 Cowen
- Evolent Health price target raised to $57 from $52 at Cowen
- 10/24/22 DA Davidson
- Winnebago price target lowered to $54 from $60 at DA Davidson
- 10/03/22 MKM Partners
- Winnebago price target lowered to $56 from $67 at MKM Partners
- 08/09/22 MKM Partners
- Winnebago cut to Neutral at MKM Partners on valuation, worsened conditions
- 08/09/22 MKM Partners
- Winnebago downgraded to Neutral from Buy at MKM Partners
- 12/16/22 Stifel
- Adobe price target raised to $400 from $375 at Stifel
- 12/16/22 Evercore ISI
- Adobe price target raised to $425 from $350 at Evercore ISI
- 12/16/22 Morgan Stanley
- Adobe price target raised to $382 from $337 at Morgan Stanley
- 12/16/22 BMO Capital
- Adobe price target raised to $390 from $332 at BMO Capital
- $264.42 /
-16.66 (-5.93%) - 12/15/22 JPMorgan
- Accenture price target raised to $327 from $306 at JPMorgan
- 12/12/22 Piper Sandler
- Accenture downgraded to Underweight from Neutral at Piper Sandler
- 10/14/22 JPMorgan
- Accenture price target lowered to $306 from $329 at JPMorgan
- 10/13/22 Wells Fargo
- Wells sees some encouraging signs from emerging metaverse app economy
- 12/14/22 Wedbush
- Darden upgraded to Outperform from Neutral at Wedbush
- 12/12/22 RBC Capital
- Darden price target raised to $155 from $144 at RBC Capital
- 12/09/22 KeyBanc
- Darden price target raised to $160 from $150 at KeyBanc
- 12/09/22 Barclays
- Darden price target raised to $146 from $136 at Barclays
- $51.85 /
+28.8 (+124.95%) - 12/16/22 Wells Fargo
- Maxar Technologies downgraded to Equal Weight from Overweight at Wells Fargo
- 12/16/22 Canaccord
- Maxar Technologies downgraded to Hold from Buy at Canaccord
- 12/16/22 Truist
- Maxar Technologies downgraded to Hold from Buy at Truist
- 11/23/22 Truist
- Maxar Technologies price target lowered to $37 from $44 at Truist
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line at Evercore ISI after reserve review
- 03/31/22 Evercore ISI
- Trean Insurance downgraded to In Line from Outperform at Evercore ISI
- 03/29/22 JPMorgan
- Trean Insurance downgraded to Neutral from Overweight at JPMorgan
- 01/14/22 JMP Securities
- Trean Insurance price target lowered to $14 from $18 at JMP Securities
- 12/16/22 JPMorgan
- Meta Platforms upgraded to Overweight from Neutral at JPMorgan
- 11/15/22 Morgan Stanley
- Meta Platforms price target lowered to $100 from $105 at Morgan Stanley
- 11/10/22 Canaccord
- Meta Platforms price target lowered to $170 from $200 at Canaccord
- 11/09/22 Itau BBA
- Meta Platforms price target raised to $120 from $102 at Itau BBA
- 12/16/22 BTIG
- BTIG upgrades Agilysys to Buy on 'game-changing contract win'
- 12/16/22 BTIG
- Agilysys upgraded to Buy from Neutral at BTIG
- 12/15/22 Craig-Hallum
- Agilysys price target raised to $80 from $65 at Craig-Hallum
- 10/26/22 Craig-Hallum
- Craig-Hallum upgrades Agilysys to Buy, raises price target to $65
- 12/16/22 Morgan Stanley
- New York Times downgraded to Equal Weight from Overweight at Morgan Stanley
- 08/11/22 Gordon Haskett
- New York Times share buys at UBS flagged by Gordon Haskett on activist link
- 08/04/22 Morgan Stanley
- New York Times price target lowered to $37 from $40 at Morgan Stanley
- 07/21/22 Guggenheim
- New York Times price target lowered to $34 from $41 at Guggenheim
- 12/16/22 JPMorgan
- AvalonBay downgraded to Underweight from Neutral at JPMorgan
- 12/08/22 Goldman Sachs
- AvalonBay downgraded to Neutral from Buy at Goldman Sachs
- 12/07/22 KeyBanc
- AvalonBay price target lowered to $193 from $237 at KeyBanc
- 12/02/22 Morgan Stanley
- AvalonBay downgraded to Equal Weight from Overweight at Morgan Stanley
- 12/12/22 Morgan Stanley
- Disney price target lowered to $115 from $125 at Morgan Stanley
- 11/30/22 Atlantic Equities
- Atlantic Equities sees 'no easy fix' for Iger at Disney
- 11/22/22 Tigress Financial
- Disney price target lowered to $177 from $229 at Tigress Financial
- 11/21/22 JPMorgan
- JPMorgan 'reluctant to recommend chasing' Disney shares on rally
- 08/10/22 Goldman Sachs
- Goldman Sachs suspends rating on Avaya amid investigations
- 08/10/22 Barclays
- Avaya price target lowered to 50c from $2 at Barclays
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 07/29/22 Craig-Hallum
- Avaya downgraded to Hold from Buy at Craig-Hallum
- 12/14/22 Wells Fargo
- Goldman Sachs price target raised to $400 from $380 at Wells Fargo
- 10/19/22 BMO Capital
- Goldman Sachs price target lowered to $469 from $470 at BMO Capital
- 10/19/22 Barclays
- Goldman Sachs price target lowered to $410 from $450 at Barclays
- 10/19/22 Oppenheimer
- Goldman Sachs price target lowered to $477 from $483 at Oppenheimer
- 12/16/22 Goldman Sachs
- American Airlines resumed with a Neutral at Goldman Sachs
- 10/17/22 Citi
- American Airlines price target lowered to $15 from $16 at Citi
- 10/12/22 Barclays
- American Airlines price target lowered to $14 from $17 at Barclays
- 10/06/22 BofA
- American Airlines price target lowered to $7 from $8 at BofA
- 11/23/22 Morgan Stanley
- Morgan Stanley wonders if 'value opportunity emerging' in Tesla after selloff
- 10/31/22 Gordon Haskett
- Gordon Haskett wonders if 'more going on' as Fertitta takes stake in Wynn
- 10/21/22 Wedbush
- Twitter deal still 'brutal situation' for Tesla holders, Wedbush says
- 10/18/22 Gordon Haskett
- Bilson sees Tesla share sale coming with Musk $8B short for Twitter
WBD Warner Bros. Discovery - 12/07/22 BofA
- Warner Bros. Discovery the 'best value in media,' says BofA
- 11/14/22 Spin-Off Research
- Warner Bros. Discovery downgraded to Hold from Buy at Spin-Off Research
- 11/10/22 Citi
- Warner Bros. Discovery price target lowered to $18 from $21 at Citi
- 11/08/22 Deutsche Bank
- Warner Bros. Discovery price target lowered to $35 from $48 at Deutsche Bank
- 12/16/22 Goldman Sachs
- Goldman says Guardant selloff, Exact Science rally an overreaction
- 12/16/22 Jefferies
- Guardant data missing expectations removes overhang on Exact, says Jefferies
- 11/14/22 Piper Sandler
- Exact Sciences price target raised to $50 from $40 at Piper Sandler
- 11/07/22 Raymond James
- Exact Sciences price target lowered to $60 from $70 at Raymond James
- 12/16/22 BofA
- Guardant Health price target raised to $70 from $65 at BofA
- 12/16/22 Cowen
- Guardant Health price target lowered to $70 from $83 at Cowen
- 12/16/22 Morgan Stanley
- Guardant's 'optical miss' presents 'compelling' entry point, says Morgan Stanley
- 11/08/22 Deutsche Bank
- Planet Labs initiated with a Buy at Deutsche Bank
- 09/13/22 Needham
- Planet Labs price target raised to $9 from $8 at Needham
- 06/15/22 Craig-Hallum
- Planet Labs price target lowered to $10 from $15 at Craig-Hallum
- 06/15/22 Needham
- Planet Labs price target lowered to $8.00 from $10.50 at Needham
- 12/16/22 Piper Sandler
- ACMG recommends 22Q screening, Natera runs micro deletion, says Piper Sandler
- 12/16/22 Stephens
- ACMG updated recommendations a positive for Natera, Myriad, says Stephens
- 11/14/22 Credit Suisse
- Natera price target lowered to $55 from $70 at Credit Suisse
- 11/10/22 Raymond James
- CareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James
- 10/06/22 Goldman Sachs
- U.S. Steel price target lowered to $18 from $21 at Goldman Sachs
- 10/04/22 Morgan Stanley
- U.S. Steel said to be idling more capacity, says Morgan Stanley
- 09/16/22 Credit Suisse
- U.S. Steel price target lowered to $37 from $44 at Credit Suisse
- 07/27/22 GLJ Research
- Cleveland-Cliffs downgraded to Sell from Buy at GLJ Research
- 11/28/22 Barrington
- Travelzoo downgraded to Market Perform from Outperform at Barrington
- 08/08/22 Ascendiant
- Travelzoo upgraded to Buy from Hold at Ascendiant
- 07/29/22 Barrington
- Travelzoo price target lowered to $10 from $12 at Barrington
- 03/18/22 Ascendiant
- Travelzoo downgraded to Hold from Buy at Ascendiant
- 12/05/22 UBS
- Steel Dynamics downgraded to Neutral from Buy at UBS
- 11/14/22 BMO Capital
- Steel Dynamics price target raised to $100 from $89 at BMO Capital
- 10/21/22 BMO Capital
- Steel Dynamics price target raised to $89 from $77 at BMO Capital
- 10/06/22 Goldman Sachs
- Steel Dynamics upgraded to Buy from Neutral at Goldman Sachs
- 12/16/22 UBS
- Sarepta upgraded to Buy at UBS ahead of 'highly likely' SRP-9001 approval
- 12/16/22 UBS
- Sarepta upgraded to Buy from Neutral at UBS
- 12/13/22 Cantor Fitzgerald
- Sarepta price target raised to $174 from $150 at Cantor Fitzgerald
- 11/28/22 Barclays
- Catalent had 483s cleared, removing overhang, says Barclays
- 12/15/22
- U.S. Steel sees Q4 adjusted EPS 58c-63c, consensus 43c
- 10/27/22
- U.S. Steel reports Q3 adjusted EPS $1.95, consensus $1.93
- 09/15/22
- U.S. Steel sees Q3 adjusted EPS $1.90-$1.95, consensus $1.90
- 07/28/22
- U.S. Steel reports Q2 EPS $3.86, consensus $3.87
- 12/16/22
- Winnebago reports Q1 adjusted EPS $2.07, consensus $1.78
- 10/19/22
- Winnebago reports Q4 adjusted EPS $3.02, consensus $2.76
- 06/22/22
- Winnebago reports Q3 adjusted EPS $4.13, consensus $2.96
WBD Warner Bros. Discovery - 11/03/22
- Warner Bros. Discovery reports Q3 EPS (95c), consensus (21c)
- 11/03/22
- Warner Bros. Discovery reports Q3 revenue $9.82B, consensus $10.36B
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 12/16/22
- Travelzoo sees Q4 revenue $18.5M, consensus $17.6M
- 10/26/22
- Travelzoo reports Q3 EPS 6c, consensus 11c
- 07/27/22
- Travelzoo sees Q3 revenue higher year-over-year, consensus $21.36M
- 07/27/22
- Travelzoo reports Q2 EPS 8c, consensus 19c
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 11/02/22
- Trean Insurance sees Q4 loss ration consistent with Q3
- 11/02/22
- Trean Insurance raises FY22 revenue outlook to $278M-$383M from $255M-$265M
- 11/02/22
- Trean Insurance reports Q3 adjusted EPS 11c, consensus 9c
- 08/03/22
- Trean Insurance reports Q2 EPS 11c, consensus 7c
- 12/15/22
- Steel Dynamics sees Q4 adjusted EPS $4.10-$4.14, consensus $3.84
- 10/19/22
- Steel Dynamics reports Q3 adjusted EPS $5.46, consensus $5.09
- 09/15/22
- Steel Dynamics sees Q3 adjusted EPS $5.33-$5.37, consensus $4.90
- 07/20/22
- Steel Dynamics reports Q2 adjusted EPS $6.73, consensus $6.05
- 11/02/22
- Sarepta reports Q EPS (80c), consensus (1.43)
- 08/02/22
- Sarepta reports Q2 EPS ($1.18), consensus ($1.18)
- 12/14/22
- Planet Labs raises FY23 revenue view to $188M-$192M from $182M-$190M
- 12/14/22
- Planet Labs sees Q4 revenue $50M-$54M, consensus $51.2M
- 12/14/22
- Planet Labs reports Q3 EPS (15c), consensus (17c)
- 09/12/22
- Planet Labs sees FY23 revenue $182M-$190M, consensus $182.03M
- 11/02/22
- New York Times reports Q3 adjusted EPS 21c, consensus 13c
- 08/03/22
- New York Times reports Q2 adjusted EPS 24c, consensus 19c
- 11/08/22
- Natera raises FY22 revenue view to $810M-$830M from $805M-$825M
- 11/08/22
- Natera reports Q3 EPS ($1.25), consensus ($1.44)
- 08/04/22
- Natera raises FY22 revenue view to $805M-$825M from $790M-$810M
- 08/04/22
- Natera reports Q2 EPS ($1.50), consensus ($1.50)
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 10/26/22
- Meta Platforms sees Q4 revenue $30B-$32.5B, consensus $32.31B
- 10/26/22
- Meta Platforms reports Q3 EPS $1.64, consensus $1.89
- 10/26/22
- Notable companies reporting after market close
- $51.85 /
+28.8 (+124.95%) - 11/03/22
- Maxar Technologies reports Q3 EPS (5c), consensus 29c
- 08/09/22
- Maxar Technologies reports Q2 EPS (41c) vs 62c last year
- 11/10/22
- IMV Inc. reports Q3 EPS (11c), consensus (15c)
- 08/11/22
- IMV Inc. reports Q2 EPS (12c), consensus (12c)
- 10/18/22
- Goldman Sachs reports Q3 EPS $8.25, consensus $7.69
- 10/17/22
- Notable companies reporting before tomorrow's open
- 07/18/22
- Goldman Sachs reports Q2 EPS $7.73, consensus $7.25
- 11/03/22
- Guardant Health cuts FY22 revenue view to $440M-$460M, consensus $461.29M
- 11/03/22
- Guardant Health reports Q3 adjusted EPS ($1.18), consensus ($1.26)
- 08/04/22
- Guardant Health backs FY22 revenue $460M-$470M, consensus $465.29M
- 08/04/22
- Guardant Health reports Q2 adjusted EPS ($1.00), consensus ($1.21)
- 11/03/22
- Exact Sciences raises FY22 revenue view to $2.025B-$2.042B, consensus $2.01B
- 11/03/22
- Exact Sciences reports Q3 EPS (84c), consensus ($1.08)
- 08/02/22
- Exact Sciences lowers FY22 revenue view to $1.980B-$2.022B from $1.985B-$2.032B
- 08/02/22
- Exact Sciences reports Q2 EPS (94c), consensus ($1.07)
- 12/16/22
- Darden revises FY23 EPS view to $7.60-$8.00 from $7.40-$8.00, consensus $7.71
- 12/16/22
- Darden reports Q2 EPS $1.52, consensus $1.43
- 12/15/22
- Notable companies reporting before tomorrow's open
- 11/08/22
- Disney CFO sees FY23 cash content spend in low-$30B range
- 11/08/22
- Disney reports Q4 EPS ex-items 30c, consensus 57c
- 11/08/22
- Notable companies reporting after market close
- 08/10/22
- Disney reports Q3 EPS ex-items $1.09, consensus $1.00
- 12/16/22
- Centene backs FY22 adjusted EPS view $5.65-$5.75, consensus $5.74
- 12/16/22
- Centene sees FY23 adjusted EPS $6.25-$6.40, consensus $6.34
- 11/17/22
- Evolent Health expects FY23 revenue growth to exceed 25%, consensus $1.64B
- 10/25/22
- Centene raises FY22 adjusted EPS view to $5.65-$5.75 from $5.60-$5.70
- 08/09/22
- Avaya sees Q3 non-GAAP EPS 24c, consensus 5c
- 07/28/22
- Avaya sees Q3 revenue $575M-$580M, below previous guidance of $685M-$700M
- 11/03/22
- AvalonBay cuts FY22 core FFO view to $9.74-$9.84 from $9.76-$9.96
- 11/03/22
- AvalonBay sees Q4 core FFO $2.55-$2.65
- 11/03/22
- AvalonBay Communities reports Q3 core FFO $2.50, consensus $2.53
- 07/27/22
- AvalonBay sees FY22 core FFO $9.76-$9.96, consensus $9.62
- 10/25/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $194.05M
- 10/25/22
- Agilysys reports Q1 adjusted EPS 24c, consensus 18c
- 07/26/22
- Agilysys backs FY23 revenue view $190M-$195M, consensus $192.84M
- 07/26/22
- Agilysys reports Q1 adjusted EPS 21c, consensus 18c
- 12/15/22
- Adobe backs FY23 adjusted EPS view $15.15-$15.45, consensus $15.25
- 12/15/22
- Adobe sees Q1 adjusted EPS $3.65-$3.70, consensus $3.64
- 12/15/22
- Adobe reports Q4 adjusted EPS $3.60, consensus $3.50
- 12/15/22
- Notable companies reporting after market close
- $264.42 /
-16.66 (-5.93%) - 12/16/22
- Accenture sees Q2 revenue $15.2B-$15.75B, consensus $15.59B
- 12/16/22
- Accenture raises FY23 EPS view to $11.20-$11.52 from $11.09-$11.41
- 12/16/22
- Accenture reports Q1 EPS $3.08, consensus $2.91
- 09/22/22
- Accenture sees Q1 revenue $15.2B-$15.75B, consensus $16.06B
- 10/20/22
- American Airlines sees Q4 EPS ex-items 50c-70c, consensus 22c
- 10/20/22
- American Airlines reports Q3 EPS 69c, consensus 56c
- 10/19/22
- Notable companies reporting before tomorrow's open
|